Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GK.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-6672.85US
XCMORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XCMENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCMENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCMNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HN.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HN.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HN.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HN.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.42.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.42.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.42.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.42.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17914.1US
HN.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-802.098France
HN.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HN.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HN.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-6672.85US
DV.7.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DV.7.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DV.7.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.7.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.20.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.20.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.20.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.20.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FY.5.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FY.5.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.5.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.5.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.13.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.13.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.13.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
HK.13.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JY.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JY.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JY.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
JY.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XCRORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XCRENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCRENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCRNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.86ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.86ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.86ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.86NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GJ.1.2.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GJ.1.2.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GJ.1.2.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GJ.1.2.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used